Seaport Therapeutics, Inc. Common Stock (SPTX) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-1.37x
Seaport Therapeutics, Inc. Common Stock (SPTX) has a Cash Flow-to-Debt Ratio of -1.37x as of June 2026, meaning its operating cash flow of $-26.14 Million could theoretically repay -1% of its total liabilities ($19.08 Million) in one year. See Seaport Therapeutics, Inc. Common Stock financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.37x
Operating CF / Total Liabilities
Operating Cash Flow
$-26.14 Million
USD
Total Liabilities
$19.08 Million
USD
Data as of
Jun 2026
Most recent filing
Seaport Therapeutics, Inc. Common Stock Cash Flow-to-Debt Ratio (2024–2025)
Historical debt coverage capacity for Seaport Therapeutics, Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see SPTX cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Seaport Therapeutics, Inc. Common Stock (2024–2025)
Year-by-year debt coverage analysis for Seaport Therapeutics, Inc. Common Stock.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.23x | $-77.94 Million | $341.55 Million | ▼ -162.3% |
| 2024 | -0.09x | $-29.63 Million | $340.63 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.